Shruti Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shruti Gupta has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Mithu Banerjee
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
5 shared publications - Jyoti Kanwar Shekhawat
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
4 shared publications - Kavya Gauba
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
4 shared publications - Prasenjit Mitra
Department of Biochemistry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
3 shared publications - Praveen Sharma
Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Jodhpur, India
3 shared publications - Arvind Rajwanshi
Department of Cytology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 shared publications
Latest Publications
- 3 October 2026
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 28 (1) , 53
Markers and Enrichment Strategies for Brain-Derived Extracellular Vesicles: Current Evidence, Limitations and Future Directions
- 3 October 2026
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 28 (1) , 53
Markers and Enrichment Strategies for Brain-Derived Extracellular Vesicles: Current Evidence, Limitations and Future Directions
- 7 November 2022
- Published by Elsevier in Microbes and Infection
- Vol. 25 (4) , 105075
Gene expression, levels and polymorphism (Ala16Val) of mitochondrial superoxide dismutase in tuberculosis patients of Rajasthan
- 7 November 2022
- Published by Elsevier in Microbes and Infection
- Vol. 25 (4) , 105075
Gene expression, levels and polymorphism (Ala16Val) of mitochondrial superoxide dismutase in tuberculosis patients of Rajasthan
- Open Access
- 6 January 2022
- Published by Scientific Scholar in Cytojournal
- Vol. 19, 1
Cytomorphological spectrum of metastatic bone tumors: Experience at a tertiary care center
Objectives: Bone is a frequent site of metastases and typically indicates a short-term prognosis in cancer patients. The majority of skeletal metastases are due to breast and prostate cancer. Bone metastasis is actually much more common than primary bone cancers, especially in adults. Fine-needle aspiration cytology (FNAC) provides reasonably accurate pre-operative diagnosis in vast majority of cases. This study aims to elicit the cytomorphological detail of various metastatic bone tumors. Material and Methods: A total of 109 cases of tumors metastatic to bone have been included in this study. The details of the cases were available from the archives of the department of cytology. May Grunwald Giemsa and hematoxylin and eosin stained smears were studied and examined for the cytomorphological spectrum. Cell block and immunohistochemistry tests were done, wherever feasible. Results: Among 109 patients, the mean age was 54.52 years. There was male preponderance with 90 males and 19 females. The most common site of metastases was in the vertebra (82 cases), and 76 cases were in the dorsolumbar region. The most common type of tumor metastasizing was adenocarcinoma. Conclusion: FNAC is a very useful, economical procedure. There are characteristic cytological features of the metastatic lesions and the basic diagnostic categorization of the malignant tumors is possible on FNAC. Regarding the primary source clinical history, radiological features of the primary tumor, if any, and immunocytochemistry may be needed.
- 6 January 2022
- Published by Scientific Scholar in Cytojournal
- Vol. 19, 1
Open AccessCytomorphological spectrum of metastatic bone tumors: Experience at a tertiary care center
Objectives: Bone is a frequent site of metastases and typically indicates a short-term prognosis in cancer patients. The majority of skeletal metastases are due to breast and prostate cancer. Bone metastasis is actually much more common than primary bone cancers, especially in adults. Fine-needle aspiration cytology (FNAC) provides reasonably accurate pre-operative diagnosis in vast majority of cases. This study aims to elicit the cytomorphological detail of various metastatic bone tumors. Material and Methods: A total of 109 cases of tumors metastatic to bone have been included in this study. The details of the cases were available from the archives of the department of cytology. May Grunwald Giemsa and hematoxylin and eosin stained smears were studied and examined for the cytomorphological spectrum. Cell block and immunohistochemistry tests were done, wherever feasible. Results: Among 109 patients, the mean age was 54.52 years. There was male preponderance with 90 males and 19 females. The most common site of metastases was in the vertebra (82 cases), and 76 cases were in the dorsolumbar region. The most common type of tumor metastasizing was adenocarcinoma. Conclusion: FNAC is a very useful, economical procedure. There are characteristic cytological features of the metastatic lesions and the basic diagnostic categorization of the malignant tumors is possible on FNAC. Regarding the primary source clinical history, radiological features of the primary tumor, if any, and immunocytochemistry may be needed.
- 21 June 2021
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 36 (4) , 440-450
Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm
COVID-19 has emerged as a global pandemic. It is mainly manifested as pneumonia which may deteriorate into severe respiratory failure. The major hallmark of the disease is the systemic inflammatory immune response characterized by Cytokine Storm (CS). CS is marked by elevated levels of inflammatory cytokines, mainly interleukin-6 (IL-6), IL-8, IL-10, tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ). Of these, IL-6 is found to be significantly associated with higher mortality. IL-6 is also a robust marker for predicting disease prognosis and deterioration of clinical profile. In this review, the pivotal role played by IL-6 in the immuno-pathology of COVID-19 has been illustrated. The role of IL-6 as a pleiotropic cytokine executing both pro and anti-inflammatory activities has been reviewed. ADAM 10, a metalloproteinase switches the anti-inflammatory pathway of IL-6 to pro inflammatory hence blocking the action of ADAM 10 could be a new therapeutic strategy to mitigate the proinflammatory action of IL-6. Furthermore, we explore the role of anti-IL6 agents, IL-6 receptor antibodies which were being used for autoimmune diseases but now are being repurposed for the therapy of COVID-19.
- 21 June 2021
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 36 (4) , 440-450
Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm
COVID-19 has emerged as a global pandemic. It is mainly manifested as pneumonia which may deteriorate into severe respiratory failure. The major hallmark of the disease is the systemic inflammatory immune response characterized by Cytokine Storm (CS). CS is marked by elevated levels of inflammatory cytokines, mainly interleukin-6 (IL-6), IL-8, IL-10, tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ). Of these, IL-6 is found to be significantly associated with higher mortality. IL-6 is also a robust marker for predicting disease prognosis and deterioration of clinical profile. In this review, the pivotal role played by IL-6 in the immuno-pathology of COVID-19 has been illustrated. The role of IL-6 as a pleiotropic cytokine executing both pro and anti-inflammatory activities has been reviewed. ADAM 10, a metalloproteinase switches the anti-inflammatory pathway of IL-6 to pro inflammatory hence blocking the action of ADAM 10 could be a new therapeutic strategy to mitigate the proinflammatory action of IL-6. Furthermore, we explore the role of anti-IL6 agents, IL-6 receptor antibodies which were being used for autoimmune diseases but now are being repurposed for the therapy of COVID-19.
CARDIOVASCULAR DISEASE AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19: A STOP-COVID ANCILLARY
- 1 May 2021
- Published by Elsevier in Tuberculosis
- Vol. 128, 102077
Immunomodulation by epigenome alterations in Mycobacterium tuberculosis infection
- 1 May 2021
- Published by Elsevier in Tuberculosis
- Vol. 128, 102077
Immunomodulation by epigenome alterations in Mycobacterium tuberculosis infection
- 28 April 2021
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 147 (7) , 1869-1879
Ten–eleven translocase: key regulator of the methylation landscape in cancer
Purpose Methylation of 5th residue of cytosine in CpG island forms 5-methylcytosine which is stable, heritable epigenetic mark. Methylation levels are broadly governed by methyltransferases and demethylases. An aberration in the demethylation process contributes to the silencing of gene expression. Ten eleven translocation (TET) dioxygenase (1–3) the de novo demethylase is responsible for conversion of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosisne (5-fC) and 5-carboxycytosine (5-caC) during demethylation process. Mutations and abnormal expression of TET proteins contribute to carcinogenesis. Discovery of TET proteins has offered various pathways for the reversal of methylation levels thus, enhancing our knowledge as to how methylation effects cancer progression. Methods We searched “PubMed” and “Google scholar” databases and selected studies with the following keywords “TET enzyme”, “cancer”, “5-hmC”, and “DNA demethylation”. In this review, we have discussed combinatorial use of vitamin C in inhibiting tumour growth by enhancing the catalytic activity of TET enzymes and consequently, increasing the 5-hmC levels. 5-Hydroxymethylcytosine holds promise as a prognostic biomarker in solid cancers. The contribution of induction and suppression of TET enzymes and 5-hmC carcinogenesis are discussed in haematological and solid cancers. Results We found that TET enzymes play central role in maintaining the methylation balance. Any anomaly in their expression may dip the balance towards cancer progression. Low levels of TET enzymes and 5-hmC correlate with tumour invasion, progression and metastasis. Also, use of vitamin C enhances TET activity. Conclusion TET enzymes play vital role in shaping the methylation landscape in body. 5-hmC can be used as prognostic marker in solid cancers.
- 28 April 2021
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 147 (7) , 1869-1879
Ten–eleven translocase: key regulator of the methylation landscape in cancer
Purpose Methylation of 5th residue of cytosine in CpG island forms 5-methylcytosine which is stable, heritable epigenetic mark. Methylation levels are broadly governed by methyltransferases and demethylases. An aberration in the demethylation process contributes to the silencing of gene expression. Ten eleven translocation (TET) dioxygenase (1–3) the de novo demethylase is responsible for conversion of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosisne (5-fC) and 5-carboxycytosine (5-caC) during demethylation process. Mutations and abnormal expression of TET proteins contribute to carcinogenesis. Discovery of TET proteins has offered various pathways for the reversal of methylation levels thus, enhancing our knowledge as to how methylation effects cancer progression. Methods We searched “PubMed” and “Google scholar” databases and selected studies with the following keywords “TET enzyme”, “cancer”, “5-hmC”, and “DNA demethylation”. In this review, we have discussed combinatorial use of vitamin C in inhibiting tumour growth by enhancing the catalytic activity of TET enzymes and consequently, increasing the 5-hmC levels. 5-Hydroxymethylcytosine holds promise as a prognostic biomarker in solid cancers. The contribution of induction and suppression of TET enzymes and 5-hmC carcinogenesis are discussed in haematological and solid cancers. Results We found that TET enzymes play central role in maintaining the methylation balance. Any anomaly in their expression may dip the balance towards cancer progression. Low levels of TET enzymes and 5-hmC correlate with tumour invasion, progression and metastasis. Also, use of vitamin C enhances TET activity. Conclusion TET enzymes play vital role in shaping the methylation landscape in body. 5-hmC can be used as prognostic marker in solid cancers.
- 10 July 2020
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 35 (4) , 410-417
Obesity and COVID-19: A Fatal Alliance
Most people infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV2) are mildly symptomatic while few progress to critical illness and succumb to the infection. The disease severity is seen to be associated with increasing age and underlying comorbid conditions. Obesity, responsible for various metabolic disorders, appears to be a risk factor in determining the severity of infection despite any age group. Though this association is clinically relevant, the mechanisms underlying are not fully elucidated. SARS CoV2 enters host cell via Angiotensin Converting Enzyme 2 receptor, expression of which is upregulated in visceral fat tissue in obese people, underscoring the fact that adipose tissue is a potential reservoir for virus. Adipose tissue is also a source of many proinflammatory mediators and adipokines. High baseline C-Reactive Protein, interleukin 6, hyperleptinemia with Leptin resistance and hypoadiponectinemia associated with obesity explains the preexisting inflammatory state in obese individuals which predisposes them to worse outcomes and fatality.
- 10 July 2020
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 35 (4) , 410-417
Obesity and COVID-19: A Fatal Alliance
Most people infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV2) are mildly symptomatic while few progress to critical illness and succumb to the infection. The disease severity is seen to be associated with increasing age and underlying comorbid conditions. Obesity, responsible for various metabolic disorders, appears to be a risk factor in determining the severity of infection despite any age group. Though this association is clinically relevant, the mechanisms underlying are not fully elucidated. SARS CoV2 enters host cell via Angiotensin Converting Enzyme 2 receptor, expression of which is upregulated in visceral fat tissue in obese people, underscoring the fact that adipose tissue is a potential reservoir for virus. Adipose tissue is also a source of many proinflammatory mediators and adipokines. High baseline C-Reactive Protein, interleukin 6, hyperleptinemia with Leptin resistance and hypoadiponectinemia associated with obesity explains the preexisting inflammatory state in obese individuals which predisposes them to worse outcomes and fatality.
- 14 April 2020
- Published by Wiley in Cytopathology
- Vol. 31 (6) , 616-618
Gradually progressive parotid swelling in a male
Secretory carcinoma is a recently described salivary gland neoplasm that shares the same histologic appearance and ETV6 gene (12p13) rearrangement as secretory carcinoma of the breast.Establishing a definite diagnosis requires microscopic examination and immunohistochemical confirmation. The major cytologic differential diagnoses include myoepithelioma, myoepithelial carcinoma andacinic cell carcinoma.We present a case of a middle‐aged male with secretory carcinoma of the parotid diagnosed on fine needle aspiration cytology and immunocytochemistry on cell‐block.
- 14 April 2020
- Published by Wiley in Cytopathology
- Vol. 31 (6) , 616-618
Gradually progressive parotid swelling in a male
Secretory carcinoma is a recently described salivary gland neoplasm that shares the same histologic appearance and ETV6 gene (12p13) rearrangement as secretory carcinoma of the breast.Establishing a definite diagnosis requires microscopic examination and immunohistochemical confirmation. The major cytologic differential diagnoses include myoepithelioma, myoepithelial carcinoma andacinic cell carcinoma.We present a case of a middle‐aged male with secretory carcinoma of the parotid diagnosed on fine needle aspiration cytology and immunocytochemistry on cell‐block.